FDA Authorizes Second COVID-19 Booster Shots for Adults 50 and Up
The Food and Drug Administration on Tuesday signed off on a second booster shot for older Americans and people who are immunocompromised.
The second dose of the Pfizer-BioNTech or Moderna booster shots was authorized by the federal agency for people ages 50 and up and those with severely weakened immune systems at least four months following their first booster.
The FDA had previously only cleared the fourth doses of the Pfizer or Moderna vaccines for people ages 12 and older who were immunocompromised. That group can now get a fifth shot — three doses and two boosters — with Tuesday’s FDA authorization.
“Current evidence suggests some waning of protection over time against serious outcomes from COVID-19 in older and immunocompromised individuals,” the FDA’s vaccine chief, Dr. Peter Marks, said in a statement.
Data shows an initial booster dose is critical to protect all adults from “potentially severe outcomes” of COVID-19, Marks said. (Read more from “FDA Authorizes Second COVID-19 Booster Shots for Adults 50 and Up” HERE)
Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.
